Related Experiment Video
Updated: May 20, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
Implantable cardioverter defibrillator shock embolizes an atrial septal occluder device in Brugada syndrome
Kothandam Sivakumar1, Sreeja Pavithran, Amal Louis
1Department of Pediatric Cardiology, MIOT Hospital, 4/112, Mount Poonamalle Road, Chennai, 600089, India, drkumarsiva@hotmail.com.
Insights
Implantable cardioverter defibrillators (ICDs) in Brugada syndrome patients require atrial septal defect closure to prevent lead embolization. A rare complication occurred during testing, but the device was retrieved and the defect successfully closed.
Area of Science:
- Cardiology
- Medical Devices
- Electrophysiology
Background:
- Brugada syndrome patients with ventricular arrhythmias often require implantable cardioverter defibrillators (ICDs).
- Atrial septal defects (ASDs) in these patients necessitate closure to prevent paradoxical embolism from ICD leads.
- This case highlights a rare co-occurrence of Brugada syndrome and a large ASD.
Observation:
- A 15-year-old male with Brugada syndrome underwent transvenous ICD placement and device closure of a large ASD.
- During defibrillation threshold testing, an induced ventricular fibrillation was terminated by a shock.
- The shock caused a sudden body movement, leading to embolization of the ICD into the left atrium.
Findings:
- The ICD device embolized into the left atrium due to sudden movement during defibrillation testing.
- Successful retrieval of the embolized ICD was performed.
- The atrial septal defect was subsequently closed with a larger device.
Implications:
- This case presents an unreported complication of device closure in conjunction with ICD implantation for Brugada syndrome.
- It underscores the importance of considering mechanical complications during device testing in patients with concurrent ASDs.
- Successful management involved device retrieval and revision of the ASD closure, offering insights for similar rare scenarios.
Abstract:
Implantable cardioverter defibrillators (ICDs) are indicated in patients with Brugada syndrome with resuscitated ventricular arrhythmias. When these patients have atrial septal defects, they also need closure to prevent paradoxic embolism of thrombus from the defibrillator leads. A 15-year-old boy with Brugada syndrome had transvenous ICD placement along with device closure of a large atrial septal defect. When the defibrillation threshold was checked during device testing, a shock was delivered to terminate the induced ventricular fibrillation. The sudden jerk during this shock resulted in device embolization into the left atrium. The device was successfully retrieved and the defect closed with a larger device. This report discusses this extremely rare association of Brugada syndrome with atrial septal defect, unreported complications after device closure, and successful management of the problem.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Cardiopulmonary Resuscitation III: AED Use
Cardiomyopathy V: Interprofessional Care
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiac Catheterization II: Right Heart Catheterization
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
